WHO’s Guidance of Ethics and Governance AI Usage

By Sumona Bose

January 30, 2024

Introduction

The World Health Organization (WHO) has released new guidance on the ethics and governance of large multi-modal models (LMMs), which are generative AI technologies that have the potential to improve healthcare outcomes. The guidance includes over 40 recommendations for governments, technology companies, and healthcare providers to ensure the appropriate use of LMMs. LMMs are unique in their ability to accept various types of data inputs, such as text, videos, and images, and generate diverse outputs. They mimic human communication and can perform tasks that they were not explicitly programmed to do. These technologies have been adopted at an unprecedented rate, with platforms like ChatGPT, Bard, and Bert gaining popularity in 2023. This article will discuss WHO’s Guidance of Ethics and Governance AI Usage.

Guiding AI’s Role in Healthcare

The potential benefits of LMMs in healthcare are vast. They can be used for diagnosis and clinical care, patient-guided use, clerical and administrative tasks, medical and nursing education, and scientific research and drug development. However, there are also risks associated with the use of LMMs. They can produce false, inaccurate, biased, or incomplete statements. These could harm individuals relying on this information for their health decisions. LMMs may also be trained on poor quality or biased data, leading to potential disparities in healthcare outcomes.

WHO - Ethics And Governance of Artificial Intelligence - DigitalRosh
Figure 1: WHO Guidance on Ethics and Governance on AI for Health

The guidance also highlights broader risks to health systems, such as the accessibility and affordability of the best-performing LMMs. There is a concern that healthcare professionals and patients may develop “automation bias,” relying too heavily on LMMs and overlooking errors or improperly delegating difficult choices to these technologies. Additionally, LMMs are vulnerable to cybersecurity risks, which could compromise patient information and the trustworthiness of these algorithms.

Ensuring a multi-stakeholder framework of AI

To ensure the safe and effective use of LMMs, the WHO emphasizes the need for engagement from various stakeholders, including governments, technology companies, healthcare providers, patients, and civil society. Governments have a primary responsibility to set standards for the development and deployment of LMMs, including their oversight and regulation. The guidance recommends that governments invest in public infrastructure and provide access to computing power and public data sets while adhering to ethical principles and values. WHO’s Guidance of Ethics and Governance AI Usage can be considered as an important framework of universal applicability.

Conclusion

Developers of LMMs should involve potential users and stakeholders, including medical providers, researchers, healthcare professionals, and patients, in the design process. LMMs should be designed to perform well-defined tasks with accuracy and reliability, improving the capacity of health systems.

Reference url

Recent Posts

Oral Semaglutide Benefits: EMA Approves First Oral GLP-1 RA with Cardiovascular Perks

By HEOR Staff Writer

September 16, 2025

Novo Nordisk’s oral semaglutide (Rybelsus®) has received a significant label update from the European Medicines Agency (EMA). It is now the first and only oral glucagon-like peptide-1 receptor agonist (GLP-1 RA) approved in the EU for type 2 diabetes with proven cardiovascular benefits. This deci...
New Federal Actions to Combat Misleading Prescription Drug Ads in 2025

By João L. Carapinha

September 11, 2025

Misleading prescription drug ads have become a pressing concern in the United States, prompting decisive federal action. What are the new measures targeting deceptive pharmaceutical advertising, and how will these changes affect public health and healthcare costs? In September 2025, a
Medicare ACO Outcomes: Balancing Surgical Benefits and Costs Under the TEAM Model

By João L. Carapinha

September 9, 2025

Medicare ACO outcomes are a major focus for clinicians, policymakers, and researchers seeking to understand how Accountable Care Organization (ACO) assignment influences patient results and healthcare costs after surgery. Are ACOs improving quality and saving money for Medicare patients undergoin...